期刊
BRAIN RESEARCH
卷 1611, 期 -, 页码 8-17出版社
ELSEVIER
DOI: 10.1016/j.brainres.2015.02.044
关键词
Schizophrenia; Sensory inhibition; Auditory gating; DBA/2 mice; C3H heterozygote Chrna7 null mutant mice; Positive allosteric modulator; PAM; alpha 7 Nicotinic receptor; PNU-120596
资金
- P30 Grant [DA015663]
- P50 Grant [MH086383]
Positive allosteric modulators (PAMs) for the alpha 7 nicotinic receptor hold promise for the treatment of sensory inhibition deficits observed in schizophrenia patients. Studies of these compounds in the DBA/2 mouse, which models the schizophrenia-related deficit in sensory inhibition, have shown PAMs to be effective in improving the deficit. However, the first published clinical trial of a PAM for both sensory inhibition deficits and related cognitive difficulties failed, casting a shadow on this therapeutic approach. The present study used both DBA/2 mice, and C3H Chrna7 heterozygote mice to assess the ability of the alpha 7 PAM, PNU-120596, to improve sensory inhibition. Both of these strains of mice have reduced hippocampal alpha 7 nicotinic receptor numbers and deficient sensory inhibition similar to schizophrenia patients. Low doses of PNU-120596 (1 or 3.33 mg/kg) were effective in the DBA/2 mouse but not the C3H Chrna7 heterozygote mouse. Moderate doses of the selective alpha 7 nicotinic receptor agonist, choline chloride (10 or 33 mg/kg), were also ineffective in improving sensory inhibition in the C3H Chrna7 heterozygote mouse. However, combining the lowest doses of both PNU-120596 and choline chloride in this mouse model did improve sensory inhibition. We propose here that the difference in efficacy of PNU-120596 between the 2 mouse strains is driven by differences in hippocampal alpha 7 nicotinic receptor numbers, such that C3H Chrna7 heterozygote mice require additional direct stimulation of the alpha 7 receptors. These data may have implications for further clinical testing of putative alpha 7 nicotinic receptor PAMs. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据